electroCore to Present at 2022 Maxim Virtual Growth Conference

News and Market Data on electroCore

 

ROCKAWAY, N.J., 
March 22, 2022 (GLOBE NEWSWIRE) — 
electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that electroCore’s Chief Executive Officer,  Dan Goldberger, will be presenting at the 2022 
Maxim Virtual Growth Conference.

electroCore’s presentation will be available on-demand from 
March 28th – 30th, 2022. To view the presentation, click HERE.

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the preventive treatment of cluster headache and migraine, the acute treatment of migraine and episodic cluster headache, the acute and preventive treatment of migraines in adolescents, and paroxysmal hemicrania and hemicrania continua in adults.

For more information, visit www.electrocore.com.

Investors:
Rich Cockrell

CG Capital
404-736-3838
ecor@cg.capital